Salix Pharmaceuticals Ltd (SLXP)
Symbol Info
Listed Symbol SLXP
Name Salix Pharmaceuticals Ltd
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2014-12-31
Latest Fiscal Revenue $1,133,542,000
Latest Fiscal EPS $-6.53
Price Info
21 Day Moving Average $171.4948
21 Day EMA $169.511220
50 Day Moving Average $157.7986
50 Day EMA $158.484150
200 Day EMA $135.664730
200 Day Moving Average 137.969130
52 Week High $172.98
52 Week Low $86.00
52 Week Change $69.454800
Alpha 0.022789
Beta 0.7722
Standard Deviation 0.109045
R2 0.070388
Periods 60
Share Information
10 Day Average Volume 883,838
20 Day Average Volume 3,581,844
30 Day Average Volume 3,271,277
50 Day Average Volume 3,594,354
Outstanding Shares 64,248,533
Float Shares 64,248,533
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 581
Institute Holdings Date 2015-02-28
Institute Bought Previous 3 Months 31,858,667
Institute Holdings Percent -
Institute Sold Previous 3 Months 26,277,388
Insider Holdings Date 2015-02-28
Insider Bought Previous 3 Months 61,513
Insider Holdings Percent 2.80%
Insider Sold Previous 3 Months 22,653
Insiders Shares Owned -
Price Change
7 Day Price Change $-
7 Day Percent Change -
21 Day Price Change $0.0699921
21 Day Percent Change 0.04%
30 Day Price Change $14.8000030
30 Day Percent Change 9.37%
Month To Date Price Change $-
Month To Date Percent -
90 Day Price Change $53.879997
90 Day Percent Change 45.30%
Quarter To Date $-
Quarter To Date Percent -
180 Day Price Change $28.809998
180 Day Percent Change 20.01%
200 Day Price Change $8.580002
200 Day Percent Change 5.22%
Year To Date $57.869995
Year To Date Percent 50.35%
Profile
Description
Details
Issue Type CS
Market Cap $11,102,788,988
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding -
CEO Thomas W. D'Alonzo
Employees 1,000
Last Audit UQ
Classification
CIK 0001009356
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 8510 Colonnade Center Drive
Raleigh, NC 27615
Website http://www.salix.com
Facisimile +1 919 862-1095
Telephone +1 919 862-1000
Email
Key Ratios
Profitability
EBIT Margin -65.8
EBITDA Margin -35.6
Pre-Tax Profit Margin -7.5
Profit Margin Cont -50.77
Gross Margin 56.30
Profit Margin TOT -50.77
Income Statements
Revenue $749,168,000
Revenue Per Share $11.6605
Revenue 3 Years $23.60
Revenue 5 Years $38.08
Valuation Measures
PE Ratio -
Enterprise Value $-
Price To Sales 14.820158
Price To Free Cash 53.200000
PE High Last 5 Years -
Price To Book 46.6
Price To Cash Flow -64.4
PE Low Last 5 Years -
Price To Tangible Book -4
Financial Strength
Total Debt To Equity 11.8
Int Coverage -2.9
Current Ratio 0.7
Leverage Ratio 8.4
Quick Ratio 0.4
Long Term Debt To Capital 0.89
Assets
Receivables Turnover 7.9
Invoice Turnover 2.00
Assets Turnover 0.20
Management Effectiveness
Return Assets -11.78
Return On Equity -85.82
Return On Capital -19.97
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
SLXP
Salix
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.